| # | Name | Description | Category | Type | Source | Website |
|---|
| # | Opportunity | Type | Region / Country | Amount | Deadline | Source |
|---|---|---|---|---|---|---|
| 42201 | Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Axitinib, ATC L01EK01 Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-05-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open May 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-05-05 |
||||||
| 42202 | Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Naltrexon, ATC N07BB04 Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-05-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open May 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-05-05 |
||||||
| 42203 | Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Denosumab, ATC M05BX04 Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-05-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open May 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-05-05 |
||||||
| 42204 | Germany – Pharmaceutical products – Arzneimittelrabattverträge gem. § 130a Abs. 8 SGB V im Rahmen von Open-House-Verfahren Buyer: IKK classic | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-05-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open May 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: IKK classic | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-05-05 |
||||||
| 42205 | Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Ticagrelor, ATC B01AC24 Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-05-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open May 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-05-05 |
||||||
| 42206 | Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Formoterol, Glycopyrroniumbromid und Budesonid, ATC R03AL11 Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-05-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open May 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-05-05 |
||||||
| 42207 | Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Eisen(III)-Derisomaltose, ATC B03AC08 Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-05-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open May 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-05-05 |
||||||
| 42208 | Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Eisen(III)hydroxid-Polymaltose-Komplex, ATC B03AC01 Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-05-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open May 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-05-05 |
||||||
| 42209 | Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Liraglutid, ATC A10BJ02 Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-05-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open May 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-05-05 |
||||||
| 42210 | Lithuania – Insurance services – Dinaminės pirkimų sistemos sukūrimas Buyer: AB Lietuvos oro uostai | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2027-05-06 | Tender Procurement Contract | Lithuania | Not provided on the source page. Please check the official source. | Open May 6, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AB Lietuvos oro uostai | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2027-05-06 |
||||||
| 42211 | Lithuania – Insurance services – Dinaminės pirkimų sistemos sukūrimas Buyer: AB Lietuvos oro uostai | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2027-05-06 | Tender Procurement Contract | Lithuania | Not provided on the source page. Please check the official source. | Open May 6, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AB Lietuvos oro uostai | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2027-05-06 |
||||||
| 42212 | Lithuania – Insurance services – Dinaminės pirkimų sistemos sukūrimas Buyer: AB Lietuvos oro uostai | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2027-05-06 | Tender Procurement Contract | Lithuania | Not provided on the source page. Please check the official source. | Open May 6, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AB Lietuvos oro uostai | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2027-05-06 |
||||||
| 42213 | NIDCD Research Career Enhancement Award for Established Investigators (K18 Clinical Trial Required) The purpose of the NIDCD Research Career Enhancement Award for Established Investigators (K18) program is to enable established, p... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open May 7, 2027 Open | Grants.gov |
|
Source description
The purpose of the NIDCD Research Career Enhancement Award for Established Investigators (K18) program is to enable established, proven investigators to augment or redirect their research programs through the acquisition of new research skills to answer questions relevant to the hearing, balance, smell, taste, voice, speech and language sciences. |
||||||
| 42214 | NIDCD Research Career Enhancement Award for Established Investigators (K18 Clinical Trial Not Allowed) The purpose of the NIDCD Research Career Enhancement Award for Established Investigators (K18) program is to enable established, p... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open May 7, 2027 Open | Grants.gov |
|
Source description
The purpose of the NIDCD Research Career Enhancement Award for Established Investigators (K18) program is to enable established, proven investigators to augment or redirect their research programs through the acquisition of new research skills to answer questions relevant to the hearing, balance, smell, taste, voice, speech and language sciences. |
||||||
| 42215 | NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01 Clinical Trial Required) The purpose of the NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01) is to support comprehe... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open May 7, 2027 Open | Grants.gov |
|
Source description
The purpose of the NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01) is to support comprehensive and rigorous postdoctoral research and career development experiences in the biomedical, behavioral, or clinical sciences of promising Au.D./Ph.D. audiologists who have the potential to become productive, independent investigators in scientific health-related research fields relevant to NIDCD's mission. |
||||||
| 42216 | NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01 Independent Clinical Trial Not Allowed) The purpose of the NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01) is to support comprehe... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open May 7, 2027 Open | Grants.gov |
|
Source description
The purpose of the NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01) is to support comprehensive and rigorous postdoctoral research and career development experiences in the biomedical, behavioral, or clinical sciences of promising Au.D./Ph.D. audiologists who have the potential to become productive, independent investigators in scientific health-related research fields relevant to NIDCD's mission. |
||||||
| 42217 | Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed) The purpose of the NIH Mentored Patient-Oriented Research Career Development Award (K23) is to support the career development of i... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open May 7, 2027 Open | Grants.gov |
|
Source description
The purpose of the NIH Mentored Patient-Oriented Research Career Development Award (K23) is to support the career development of individuals with a clinical doctoral degree who have made a commitment to focus their research endeavors on patient-oriented research. |
||||||
| 42218 | NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Required) The purpose of the NIH Pathway to Independence Award (K99/R00) program is to increase and maintain a strong cohort of new and tale... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open May 7, 2027 Open | Grants.gov |
|
Source description
The purpose of the NIH Pathway to Independence Award (K99/R00) program is to increase and maintain a strong cohort of new and talented, NIH-supported, independent investigators. This program is designed to facilitate a timely transition of outstanding postdoctoral researchers with a research and/or clinical doctorate degree from mentored, postdoctoral research positions to independent, tenure-track or equivalent faculty positions. The program will provide independent NIH research support during this transition in order to help awardees to launch competitive, independent research careers. |
||||||
| 42219 | Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Not Allowed) The purpose of the NIH Midcareer Investigator Award in Patient-Oriented Research (K24) is to provide support to mid-career health-... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open May 7, 2027 Open | Grants.gov |
|
Source description
The purpose of the NIH Midcareer Investigator Award in Patient-Oriented Research (K24) is to provide support to mid-career health-professional doctorates for protected time to devote to patient-oriented research (POR) and to act as research mentors primarily for clinical residents, clinical fellows and/or junior clinical faculty. |
||||||
| 42220 | Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Required) The purpose of the NIH Midcareer Investigator Award in Patient-Oriented Research (K24) is to provide support to mid-career health-... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open May 7, 2027 Open | Grants.gov |
|
Source description
The purpose of the NIH Midcareer Investigator Award in Patient-Oriented Research (K24) is to provide support to mid-career health-professional doctorates for protected time to devote to patient-oriented research (POR) and to act as research mentors primarily for clinical residents, clinical fellows and/or junior clinical faculty. |
||||||
| 42221 | Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Required) The purpose of the Mentored Quantitative Research Career Development Award (K25) is to attract to NIH-relevant research those inve... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open May 7, 2027 Open | Grants.gov |
|
Source description
The purpose of the Mentored Quantitative Research Career Development Award (K25) is to attract to NIH-relevant research those investigators whose quantitative science and engineering research has thus far not been focused primarily on questions of health and disease. The K25 award will provide support and "protected time" for a period of supervised study and research for productive professionals with quantitative (e.g., mathematics, statistics, economics, computer science, imaging science, informatics, physics, chemistry) and engineering backgrounds to integrate their expertise with NIH-relevant research.This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing to serve as the lead investigator of an independent clinical trial, a clinical trial feasibility study, or a separate ancillary clinical trial, as part of their research and career development. Applicants not planning an independent clinical trial, or proposing to gain research experience in a clinical trial led by another investigator, must apply to companion FOA. |
||||||
| 42222 | Independent Scientist Award (Parent K02 - Independent Clinical Trial Required) The purpose of the NIH Independent Scientist Award (K02) is to foster the development of outstanding scientists and enable them to... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open May 7, 2027 Open | Grants.gov |
|
Source description
The purpose of the NIH Independent Scientist Award (K02) is to foster the development of outstanding scientists and enable them to expand their potential to make significant contributions to their field of research. The K02 award provides three to five years of salary support and "protected time" for newly independent scientists who can demonstrate the need for a period of intensive research focus as a means of enhancing their research careers. Each independent scientist career award program must be tailored to meet the individual needs of the candidate.This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing to serve as the lead investigator of an independent clinical trial, a clinical trial feasibility study, or a separate ancillary clinical trial, as part of their research and career development. Applicants not planning an independent clinical trial, or proposing to gain research experience in a clinical trial led by another investigator, must apply to companion FOA |
||||||
| 42223 | Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Not Allowed) The purpose of the Mentored Quantitative Research Career Development Award (K25) is to attract to NIH-relevant research those inve... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open May 7, 2027 Open | Grants.gov |
|
Source description
The purpose of the Mentored Quantitative Research Career Development Award (K25) is to attract to NIH-relevant research those investigators whose quantitative science and engineering research has thus far not been focused primarily on questions of health and disease. The K25 award will provide support and "protected time" for a period of supervised study and research for productive professionals with quantitative (e.g., mathematics, statistics, economics, computer science, imaging science, informatics, physics, chemistry) and engineering backgrounds to integrate their expertise with NIH-relevant research.This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor. Applicants proposing a clinical trial or an ancillary clinical trial as lead investigator, should apply to the companion FOA (). |
||||||
| 42224 | Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Required) The purpose of the NIH Mentored Research Scientist Development Award (K01) is to provide support and protected time (three to five... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open May 7, 2027 Open | Grants.gov |
|
Source description
The purpose of the NIH Mentored Research Scientist Development Award (K01) is to provide support and protected time (three to five years) for an intensive, supervised career development experience in the biomedical, behavioral, or clinical sciences leading to research independence. Although all of the participating NIH Institutes and Centers (ICs) use this support mechanism to support career development experiences that lead to research independence, some ICs use the K01 award for individuals who propose to train in a new field or for individuals who have had a hiatus in their research career because of illness or pressing family circumstances. |
||||||
| 42225 | Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) The purpose of the NIH Mentored Research Scientist Development Award (K01) is to provide support and protected time (three to five... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open May 7, 2027 Open | Grants.gov |
|
Source description
The purpose of the NIH Mentored Research Scientist Development Award (K01) is to provide support and protected time (three to five years) for an intensive, supervised career development experience in the biomedical, behavioral, or clinical sciences leading to research independence. Although all of the participating NIH Institutes and Centers (ICs) use this support mechanism to support career development experiences that lead to research independence, some ICs use the K01 award for individuals who propose to train in a new field or for individuals who have had a hiatus in their research career because of illness or pressing family circumstances. Other ICs use the K01 to support career development in specific fields.This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or a separate ancillary clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor. Applicants proposing a clinical trial or an ancillary clinical trial as lead investigator, should apply to the companion NOFO. |
||||||